• Diabetes 01.12.2025 No Comments

    Top Type 1 Diabetes Research Breakthroughs to Watch in 2025

    Over the last twenty years, as technology has advanced at lightning speed, the T1D community has undergone its own transformation, with digital health and cutting-edge research driving remarkable diabetes breakthroughs.

    Top Type 1 Diabetes Research Breakthroughs to Watch in 2025

    New and improved insulin pumps and continuous glucose monitors (CGMs), artificial pancreas systems, beta cell regeneration, encapsulation, bionic pump therapy—plus clinical trials happening right now that render individuals insulin independent.

    These trailblazing discoveries alone should be reason enough to commemorate this time in history and hope for even broader breakthroughs on the T1D horizon.

    Type 1 Diabetes Research in 2025

    When someone is diagnosed with type 1 diabetes, the first question they and their loved ones ask is how close are scientists to finding a cure? Since the discovery of insulin in 1921 (over 100 years ago!), diabetes treatment and technological advancements for the chronic disease have come in waves. Now, finally, the pendulum appears to be swinging with upward momentum.

    Thanks to the American Diabetes Association (ADA), Breakthrough T1D (formerly JDRF)Diabetes Research Institute and continued government funding for the Special Diabetes Program (SDP), exploration into a cure continues to grow. More specifically, treatments to reverse, slow down and aid individuals with type 1 diabetes seem to have had a resurgence of late.

    What’s more, StartUp Health’s T1D Moonshot Program offers opportunities to entrepreneurs, scientists and philanthropists to accelerate innovation toward managing the disease and finding a cure for T1D.

    T1D Advances on the Horizon

    When someone thinks of a cure – they expect the illness or disease to cease from being. There is hope for a biological cure for T1D. Ideally, concerning type 1 diabetes care, a cure requires the body to start producing its own insulin again and normalizing blood sugar levels without the added risk of immunosuppression drug side effects.

    Here are some diabetes breakthroughs to watch for – that keep improving.

    Diabetes Devices: High Tech Insulin Pump Therapy

    The Cutting Edge of Automated Insulin Delivery

    To continue reading the rest of this story, please click (HERE)

  • Big Changes Are Coming for 2026 Medicare Plans. What You Need to Know.

    Skinnier benefits, higher premiums and fewer options mean more than a million seniors should shop for new coverage during open enrollment

    Illustration of pills with dollar signs.

    Alexandra Citrin-Safadi/WSJ

    Last year, seniors picking Medicare coverage faced some tough choices. This year might be even worse.

    The enrollment period for 2026 Medicare coverage starts Wednesday, and it is likely to be a difficult one for many enrollees. For the second year in a row, big Medicare insurers are getting rid of some plans, trimming popular benefits and increasing out-of-pocket costs such as deductibles.

    The upshot: Seniors have to be careful, or they might end up with a bad surprise such as higher drug costs or the loss of a favorite doctor.

    “This year is a nightmare,” said Marcia Mantell, a retirement-planning consultant. Medicare enrollees “have to know more than they ever have had to know…it’s all the hidden stuff,” she said.

    Behind the turmoil are business realities. Medicare insurers have seen their profits squeezed by higher-than-expected medical spending and regulatory changes. Now, some of the biggest are trying to improve their margins by dumping unprofitable products and by controlling costs better.

    The moves might make their products less appealing. The industry is projecting that enrollment in private Medicare plans, known as Medicare Advantage, will shrink in 2026. That would be the first time in 15 years, according to the health researcher KFF.

    “What many of the companies have talked about is really pricing for profitability rather than for growth,” said Lisa Gill, a senior analyst at J.P. Morgan.

    Here’s what you need to know about navigating this year’s Medicare enrollment pitfalls.

    Read more …

  • Premiered Nov 12, 2025
    Join us as we delve into the latest breakthroughs in diabetes research and explore a potential cure that’s been making waves in the medical community. Could this innovative approach finally provide relief to millions of people living with diabetes? In this video, we’ll examine the science behind this promising treatment and discuss what it could mean for the future of diabetes management. From the potential benefits to the possible risks, we’ll leave no stone unturned in our quest to understand the implications of this groundbreaking discovery. If you or a loved one is affected by diabetes, you won’t want to miss this thought-provoking exploration of a potential cure.

  • Gene therapy for diabetes. It sounds like pure science fiction, something that’s decades away. But what if it wasn’t? This concept isn’t just a far-off dream. In fact, AAV gene therapy is already FDA-approved and working in other medical fields. And for diabetes, its approval is right around the corner. We get that this is a confusing, complex topic—even for providers—which is exactly why we recorded this podcast.

    Here’s what you’ll learn:

    • What AAV gene therapy is (delivering a DNA “blueprint” for a protein like insulin).
    • Why this is a “one and done” therapy that could last for years, or even a lifetime.
    • How a harmless, engineered virus (called an AAV vector) is used as a “delivery truck.”
    • How this new diabetes treatment could work for anyone, even if you’ve had diabetes for 100 years.
    • Other FDA approved therapies that use gene therapy technology
    • How this approach could allow your own muscle tissue to produce insulin.
    • The realistic timeline: Why this is here now, with human trials on the horizon.
  • Diabetes 01.11.2025 No Comments
    Today is the first day of November, aka Diabetes Awareness Month.
    Here are the numbers since my Type-1 Diabetes diagnosis on November 15, 1976:
    48.96 years = 595 months = 2,554 weeks = 17,883 days